Gilead Sciences Inc
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.
What If You Bought GILD Earlier?
Estimate based on split history only. Excludes dividends, fees, taxes, and intraday movement.
Stock Split History
Newest split first. Cumulative multiple = compounded growth from that date to today.
| Split Date | Price Before | Ratio | Split Multiple | Cumulative |
|---|---|---|---|---|
| Jan 28, 2013 | $79.36 | 2-for-1 | 2× | 32× |
| Jun 25, 2007 | $78.48 | 2-for-1 | 2× | 16× |
| Sep 7, 2004 | $70.32 | 2-for-1 | 2× | 8× |
| Mar 8, 2002 | $71.72 | 2-for-1 | 2× | 4× |
| Feb 22, 2001 | $66.12 | 2-for-1 | 2× | 2× |
Gilead Sciences Inc Market Cap Timeline
Market capitalization is available from 1996; the sourced public-listing year is 1992, so earlier annual values remain unavailable. Split markers cover all 5 recorded splits. Filled dots have market-cap data for that year; hollow dots mark split years outside market-cap source coverage.